期刊
ADVANCED DRUG DELIVERY REVIEWS
卷 75, 期 -, 页码 32-52出版社
ELSEVIER
DOI: 10.1016/j.addr.2014.04.005
关键词
Carrier-free; Dry powder inhalers; Particle engineering; Porous particles; Inhaler devices; Inhaler excipients
资金
- Science Foundation Ireland [12/RC/2275, 12/IP/1408]
- Science Foundation Ireland (SFI) [12/IP/1408] Funding Source: Science Foundation Ireland (SFI)
Dry powder inhaler (DPI) products have traditionally comprised a simple formulation of micronised drug mixed with a carrier excipient, typically lactose monohydrate. The presence of the carrier is aimed at overcoming issues of poor flowability and dispersibility, associated with the cohesive nature of small, micronised active pharmaceutical ingredient (API) particles. Both the powder blend and the DPI device must be carefully designed so as to ensure detachment of the micronised drug from the carrier excipient on inhalation. Over the last two decades there has been a significant body of research undertaken on the design of carrier-free formulations for DPI products. Many of these formulations are based on sophisticated particle engineering techniques; a common aim in formulation design of carrier-free products being to reduce the intrinsic cohesion of the particles, while maximising dispersion and delivery from the inhaler. In tandem with the development of alternative formulations has been the development of devices designed to ensure the efficient delivery and dispersion of carrier-free powder on inhalation. In this review we examine approaches to both the powder formulation and inhaler design for carrier-free DPI products. (C) 2014 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据